Medifirst Solutions Sets Pricing for Flagship Product

Medifirst Solutions Sets Pricing for Flagship Product

By: Dylan Sikes - AllPennyStocks.com News

Monday, July 18, 2016

U.S. stocks continued to hover around record highs as the rally continues. All three benchmark indexes are up sharply in mid-day trading today. Investors have brushed aside developments in Turkey over the weekend and are focusing on the ongoing earnings season in the U.S. The earnings season kicked off last week with aluminum giant Alcoa Inc. (NYSE:AA) reporting better-than-expected earnings. Following Alcoa, major U.S. banks also reported strong results. JP Morgan Chase & Co. (NYSE:JPM) reported strong results last week. Earlier today, Bank of America Corporation (NYSE:BAC) reported better-than-expected earnings and revenue for the second quarter.


The ongoing earnings season is expected to be strong as the negative impact of a stronger dollar is not likely to have been felt in the second quarter. Although the dollar has strengthened post the Brexit vote, its impact will be felt in the third quarter.

A strong earnings season could push U.S. stocks to new highs in the coming weeks. However, with stocks now at record highs, there are some concerns about valuations. Indeed, valuations look extremely stretched, with the price to earnings ratio for the S&P 500 well above the average multiple for the last decade.

One of the major movers in trading today is Medifirst Solutions Inc. (OTCPK:MFST). Based in Freehold, New Jersey, Medifirst Solutions seeks innovative medical and healthcare products and technologies which are targeted to both medical and healthcare professionals, as well as everyday consumers. Medifirst is developing and establishing both consumer and professional medical clientele that can serve as a pipeline that will allow for distribution of future products and services.

MFST shares are seeing significant activity after the company provided an update regarding its flagship product, the infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The company said that in received clearance from the U.S. Food and Drug Administration ("FDA") to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device following its Premarket Notification 510(k) submission. MFST said that it has set a price for the Infrared Time Machine Laser at $9,995, which includes a two-year warranty. It is anticipated that healthcare professionals will also have the option to finance or lease the laser units.

At last check, MFST shares were trading 7.78% lower at $0.0166 on volume of 4.96 million, which is well above the daily average volume of 2.92 million, however this down day is on the heels of a strong move higher in recent days.

Copyright © 2016 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Unexpected Copper Concentration Sends Shares of this Junior Miner Higher
Biotech Steals The Show Following Pre-Clinical Data Announcement
Micro Cap Up Big Following Acquisition Rumor
Most Popular
FREE Newsletter


Back to Top